Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biochemical Journal

• Publication date

  2002-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BJ20021054PMID 12220225PMCID PMC1223032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• References Subscriptions Permissions Email Alerts TCR Signaling Thresholds Regulating T Cell Development and Activation Are Dependent

  2013cited by this paper
• Molecular interactions of SHP1 and SHP2 in IL-3-signalling.

  2002cited by this paper
• Phosphoinositide 3-Kinase-dependent Regulation of Interleukin-3-induced Proliferation

  2001cited by this paper
• Sodium Stibogluconate Is a Potent Inhibitor of Protein Tyrosine Phosphatases and Augments Cytokine Responses in Hemopoietic Cell Lines1

  2001cited by this paper
• Mutation of the Hematopoietic Cell Phosphatase (Hcph) Gene Is Associated with Resistance to γ-Irradiation-Induced Apoptosis in Src Homology Protein Tyrosine Phosphatase (SHP)-1-Deficient “Motheaten” Mutant Mice1

  2001cited by this paper
• Cytosolic Tyrosine Dephosphorylation of STAT5

  2000cited by this paper
• STAT proteins and transcriptional responses to extracellular signals.

  2000cited by this paper
• Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling.

  2000cited by this paper
• Dissociation of Apoptosis from Proliferation, Protein Kinase B Activation, and BAD Phosphorylation in Interleukin-3-mediated Phosphoinositide 3-Kinase Signaling*

  1999cited by this paper
• Regulation of Acidification and Apoptosis by SHP-1 and Bcl-2*

  1999cited by this paper
• Organization and regulation of mitogen-activated protein kinase signaling pathways.

  1999cited by this paper
• The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.

  1999cited by this paper
• Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection.

  1999cited by this paper
• Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1.

  1999cited by this paper
• Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family.

  1998cited by this paper
• Identification of Major Binding Proteins and Substrates for the SH2-Containing Protein Tyrosine Phosphatase SHP-1 in Macrophages

  1998cited by this paper
• Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells.

  1998cited by this paper
• Protein tyrosine phosphatases in signal transduction.

  1997cited by this paper
• SHP1 and SHP2 protein-tyrosine phosphatases associate with betac after interleukin-3-induced receptor tyrosine phosphorylation. Identification of potential binding sites and substrates.

  1997cited by this paper
• Interleukin-3 Induces Association of the Protein-tyrosine Phosphatase SHP2 and Phosphatidylinositol 3-Kinase with a 100-kDa Tyrosine-phosphorylated Protein in Hemopoietic Cells*

  1997cited by this paper
• Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction.

  1997cited by this paper
• Interaction of Growth Hormone-activated STATs with SH2-containing Phosphotyrosine Phosphatase SHP-1 and Nuclear JAK2 Tyrosine Kinase*

  1997cited by this paper
• Hematopoietic cell protein-tyrosine phosphatase-deficient motheaten mice exhibit T cell apoptosis defect.

  1996cited by this paper
• Mechanism of activation of protein kinase B by insulin and IGF‐1.

  1996cited by this paper
• Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1.

  1996cited by this paper
• Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1

  1996cited by this paper
• Suppression of interleukin‐3‐induced gene expression by a C‐terminal truncated Stat5: role of Stat5 in proliferation.

  1996cited by this paper
• Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1

  1996cited by this paper
• Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1

  1995cited by this paper
• Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals.

  1995cited by this paper
• Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling

  1995cited by this paper
• Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo

  1995cited by this paper
• Identification of a viability domain in the granulocyte/macrophage colony-stimulating factor receptor beta-chain involving tyrosine-750.

  1995cited by this paper
• Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites.

  1995cited by this paper
• Activation of src-related tyrosine kinases by IL-3.

  1995cited by this paper
• Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3'-kinase.

  1994cited by this paper
• Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor beta chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis

  1993cited by this paper
• Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene.

  1993cited by this paper
• Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5.

  1993cited by this paper
• Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction.

  1993cited by this paper
• Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene

  1993cited by this paper
• Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5

  1993cited by this paper
• Two distinct functional high affinity receptors for mouse interleukin‐3 (IL‐3).

  1992cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences

  1992cited by this paper
• Isolation of a src homology 2-containing tyrosine phosphatase.

  1992cited by this paper
• An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT.

  1991cited by this paper
• The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells

  1989cited by this paper
• Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev).

  1989cited by this paper

• Kaempferide triggers apoptosis and paraptosis in pancreatic tumor cells by modulating the ROS production, SHP‐1 expression, and the STAT3 pathway

  2024cites this paper
• SHP-1 phosphatase acts as a coactivator of PCK1 transcription to control gluconeogenesis

  2023cites this paper
• MARCH3 negatively regulates IL-3-triggered inflammatory response by mediating K48-linked polyubiquitination and degradation of IL-3Rα

  2022cites this paper
• Molecular Features Underlying Shp1/Shp2 Discrimination by Immune Checkpoint Receptors

  2021cites this paper
• Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors

  2021cites this paper
• Microbially Guided Discovery and Biosynthesis of Biologically Active Natural Products.

  2020cites this paper
• Chromatin alterations during transformation of B cells by a constitutively active mutant of STAT5

  2019cites this paper
• Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T

  2018cites this paper
• Transcriptional regulation by the oncoprotein STAT5: role of acetylation and deacetylation processes

  2017cites this paper
• WMJ‐8‐B, a novel hydroxamate derivative, induces MDA‐MB‐231 breast cancer cell death via the SHP‐1‐STAT3‐survivin cascade

  2017cites this paper
• WMJ-8B , a novel hydroxamate derivative , induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT 3-survivin cascade

  2017cites this paper
• Examination of potential mechanisms linking AMPK to inhibition of IL-6 signalling

  2017cites this paper
• The Inhibitory Signaling Receptor Protocadherin-18 Regulates Tumor-Infiltrating CD8+ T-cell Function

  2017cites this paper
• Paradoxical onset of psoriasis after IL-6 receptor blockade

  2015cites this paper
• Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma

  2015cites this paper
• A Novel Lentiviral Vector Model to Investigate the Mechanism of Insertional Mutagenesis by Aberrant Splicing

  2015cites this paper
• Protein tyrosine phosphatases as wardens of STAT signaling.

  2014cites this paper
• Elevated postinjury thrombospondin 1–CD47 triggering aids differentiation of patients' defective inflammatory CD1a+dendritic cells

  2014cites this paper
• Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors

  2014cites this paper
• Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B cell cytotoxicity in chronic lymphocytic leukemia

  2014cites this paper
• Identification of Semaphorin 4B as a Negative Regulator of Basophil-Mediated Immune Responses

  2011influential citation
• Deficiency of SHP1 leads to sustained and increased ERK activation in mast cells, thereby inhibiting IL-3-dependent proliferation and cell death.

  2011cites this paper
• Negative Regulator of Basophil-Mediated Identification of Semaphorin 4 B as a Katayama and

  2011influential citation
• SHP-1 Deficient Mast Cells Are Hyperresponsive to Stimulation and Critical in Initiating Allergic Inflammation in the Lung

  2009cites this paper
• Phosphatase inhibition augments anti-CD22-mediated signaling and cytotoxicity in non-hodgkin's lymphoma cells.

  2009cites this paper
• Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling

  2009cites this paper
• Treatment of non-Hodgkin’s lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy

  2009cites this paper
• Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.

  2009cites this paper
• Role of PTEN in the Tumor Microenvironment

  2009cites this paper
• DEFINING THE ROLE OF THE SHP2 PROTEIN TYROSINE PHOSPHATASE IN FcepsilonRI SIGNALING IN MAST CELLS

  2009cites this paper
• SHP-1 differentially regulates LPS-mediated TNF-alpha and IL-10 production in murine splenic macrophages

  2009cites this paper
• DEFINING THE ROLE OF THE SHP2 PROTEIN TYROSINE PHOSPHATASE IN FcɛRI SIGNALING IN MAST CELLS

  2008cites this paper
• Protein tyrosine phosphatases in the JAK/STAT pathway.

  2008cites this paper
• Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels

  2008cites this paper
• DJ-1 , a Parkinson ’ s Disease-associated Gene , Prevent Excessive Glial Inflammatory Responses through Interaction with SHP-1 by

  2008cites this paper
• Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*

  2008cites this paper
• Promoter‐specific induction of the phosphatase SHP‐1 by viral infection and cytokines in CNS glia

  2008cites this paper
• Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5.

  2008cites this paper
• The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

  2007cites this paper
• Differential Regulation of Interleukin 5-stimulated Signaling Pathways by Dynamin*

  2006cites this paper
• Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells.

  2006cites this paper
• Loss of SHP 1 enhances JAK 3 / STAT 3 signaling and decreases proteosome degradation of JAK 3 and NPM-ALK in ALK anaplastic large-cell lymphoma

  2006cites this paper
• Loss of SHP 1 Enhances JAK 3 / STAT 3 Signaling and Decreases Proteosome Degradation of JAK 3 and NPM-ALK in ALK-positive Anaplastic Large Cell Lymphoma

  2006cites this paper
• SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis

  2006cites this paper
• To study the associations between SHP-1 methylation in normal epithelial tissues and demethylation in psoriasis

  2006cites this paper
• Regulation of avoidant behaviors and pain by the anti-inflammatory tyrosine phosphatase SHP-1.

  2006influential citation
• observations on the Southern Cerrados and their Relationship with the Core Area

  2006cites this paper
• Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma.

  2006cites this paper
• Tyrosine phosphatase SHP-1 acts at different stages of development to regulate hematopoiesis.

  2005cites this paper
• The signaling mechanism of eosinophil activation

  2005cites this paper
• Increased Myeloproliferation in Glutathione S-Transferase π-deficient Mice Is Associated with a Deregulation of JNK and Janus Kinase/STAT Pathways*

  2004cites this paper
• Environmental estrogens can affect the function of mussel hemocytes through rapid modulation of kinase pathways.

  2004cites this paper
• Monophosphate and Phosphatases ′ , 5 ′ Lymphocytes : Role of Cyclic Adenosine 3 Phosphorylation of STAT 5 in T Inhibit IL-2-Induced Tyrosine Receptors to 2 Adenosine Acts through

  2004cites this paper
• Lymphocytes : Role of Cyclic Adenosine 3 Phosphorylation of STAT 5 in T Inhibit IL-2-Induced Tyrosine Receptors to 2 Adenosine Acts through

  2004cites this paper
• Adenosine Acts through A2 Receptors to Inhibit IL-2-Induced Tyrosine Phosphorylation of STAT5 in T Lymphocytes: Role of Cyclic Adenosine 3′,5′-Monophosphate and Phosphatases1

  2004cites this paper
• The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.

  2004cites this paper
• The coupling of TEL/PDGFβR to distinct functional responses is modulated by the presence of cytokine: involvement of mitogen-activated protein kinases

  2003cites this paper
• The coupling of TEL/PDGFbetaR to distinct functional responses is modulated by the presence of cytokine: involvement of mitogen-activated protein kinases.

  2003cites this paper
• Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).

  2003cites this paper
• Molecular features underlying differential SHP 1 / SHP 2 binding of immune 1 checkpoint receptors 2

  year unknowncites this paper